With so many biosimilars in the pipeline, the federal government has its hands full. To better understand what Fall has in store, we spoke with Dr. Sarfaraz Niazi.
With so many biosimilars in the pipeline, the federal government has its hands full. To better understand what Fall has in store, we spoke with Dr. Sarfaraz Niazi.